Quetiapine discontinuation syndrome

Am J Psychiatry. 2005 May;162(5):1020. doi: 10.1176/appi.ajp.162.5.1020.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / therapeutic use
  • Bipolar Disorder / drug therapy
  • Dibenzothiazepines / adverse effects*
  • Dibenzothiazepines / therapeutic use
  • Female
  • Humans
  • Nausea / chemically induced
  • Nausea / drug therapy
  • Prochlorperazine / therapeutic use
  • Quetiapine Fumarate
  • Substance Withdrawal Syndrome / drug therapy
  • Substance Withdrawal Syndrome / etiology*
  • Treatment Outcome

Substances

  • Antipsychotic Agents
  • Dibenzothiazepines
  • Quetiapine Fumarate
  • Prochlorperazine